In the third quarter, ICU Medical grew revenue and adjusted EBITDA by 4.4% and 7.5%, respectively, and the firm beat consensus estimates on the top and bottom lines. Management maintained its guidance for 2026 but shared that it expects to land near the high end of the range.
Management has done an impressive job deepening ICU's consumables portfolio through acquisitions and bolstering its leading position in this attractive end market.
ICU has struggled to consolidate its Smiths Medical acquisition, which has led to additional restructuring costs and has cast doubt on the firm’s ability to successfully integrate acquisitions.
Metric | ICUI | BAX | BDX |
|---|---|---|---|
Price/Earnings (Normalized) | 21.99 | 12.95 | 30.42 |
Price/Book Value | 2.08 | 2.10 | 2.35 |
Price/Sales | 2.10 | 1.17 | 3.06 |
Price/Cash Flow | 12.59 | 11.73 | 16.28 |
Metric | ICUI | BAX | BDX |
|---|---|---|---|
Quick Ratio | 1.05 | 0.99 | 0.33 |
Current Ratio | 2.37 | 1.79 | 0.87 |
Interest Coverage | 1.38 | 0.21 | 4.15 |
Metric | ICUI | BAX | BDX |
|---|---|---|---|
Return on Assets (Normalized) | 3.76% | 4.82% | — |
Return on Equity (Normalized) | 7.05% | 15.04% | — |
Return on Invested Capital (Normalized) | 5.87% | 7.23% | — |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|dcSG%t@H | LOCK|#m^ | $156B | |||
| Becton Dickinson & Co BDX | LOCK|?%M | LOCK|V#%h | $58B | |||
| Alcon Inc ALC | LOCK|xQ#&T< | LOCK|!D!JD | $36B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|&!&@mP# | LOCK|Y!$> | $36B | |||
| ResMed Inc RMD | LOCK|<!kh&Xs% | LOCK|cFQ# | $33B | |||
| West Pharmaceutical Services Inc WST | LOCK|&bgbbC^ | LOCK|k& | $29B | |||
| Solventum Corp SOLV | LOCK|<<!yss | LOCK|%@ | $15B | |||
| Baxter International Inc BAX | LOCK|hq | LOCK|#J<mK | $14B | |||
| Align Technology Inc ALGN | LOCK|<Q>^Q#g | LOCK|$D>%p | $12B | |||
| The Cooper Companies Inc COO | LOCK|<>c>#K& | LOCK|#qSp | $12B |
United States